Undesirable drug effects and interactions: What should be kept in mind when using St Johnes wort preparations;Unerwünschte arzneimittelwirkungen und -interaktionen: Woran sollte man denken bei der Gabe von Johanniskrautpräparaten?

Pharmazie in Unserer Zeit

Volumn 32, Issue 3, 2003, Pages 242-246

  Johne, Andreas ^a   Roots, Ivar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANTICOAGULANT AGENT; BUSPIRONE; CHLOROQUINE; CYCLOSPORIN; DICLOFENAC; DOSULEPIN; FENFLURAMINE; FENTANYL DERIVATIVE; GINKGO BILOBA EXTRACT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; ISOFLURANE; LOPERAMIDE; NEFAZODONE; NEVIRAPINE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PROPOFOL; SERTRALINE; SEVOFLURANE; SUXAMETHONIUM; TACROLIMUS; TESTOSTERONE; THEOPHYLLINE DERIVATIVE; TRAZODONE; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; VALERIAN; VENLAFAXINE;

ARTICLE; DELIRIUM; DEPRESSION; DRUG EFFECT; ERYTHEMA; HUMAN; HYPOMANIA; HYPOTENSION; LETHARGY; MANIA; NEUROTOXICITY; PHARMACODYNAMICS; PHOTOTOXICITY; SEROTONIN SYNDROME; SHOCK; SIDE EFFECT;

ANIMALS; ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; DERMATITIS, PHOTOTOXIC; DRUG INTERACTIONS; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; PHARMACOKINETICS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 0037620409     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.200390072     Document Type: Article

References (8)

1. Schulz, V.: Incidence and clinical relevance of the interactions and side effects of Hypericum preparations. Phytomedicine 8 (2001), 152-160.
2. Schempp, C.M., Müller, K.A., Winghofer, B., Schöpf, E. und Simon, J.C.: Johanniskraut (Hypericum perforatum L.). Eine Pflanze mit Relevanz für die Dermatologie. Hautarzt 53 (2002), 316-321.
3. Brockmöller, J., Reum, T., Bauer, S., Kerb, R., Hübner, W.D., and Roots, I.: Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30 Suppl 2 (1997), 94-101.
4. Lantz, M.S., Buchalter, E., and Giambanco, V.: St. John's Wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol 12 (1999), 7-10.
5. Johne, A., Mai, I., Bauer, S., Krüger, H., Arold, G., Störmer, E., Gerloff, T., und Roots I.: Übersicht zu Interaktionsstudien mit Johanniskraut-Extrakten (2001). In: V. Schulz, N. Rietbrock, I. Roots, D. Loew (Ed.): Phytopharmaka VII Forschung und klinische Anwendung, Steinkopff Verlag, Darmstadt, 149-161.
6. Johne, A., Brockmöller, J., Bauer, S., Maurer, A., Langheinrich, M., and Roots, I.: Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 66 (1999), 338-345.
7. Henderson, L., Yue, Q. Y., Bergquist, C., Gerden, B., and Arlett, P.: St John's Wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 54 (2002), 349-356.
8. Johne, A., Schmider, J., Brockmöller, J., Stadelmann, A.M., Störmer, E., Bauer, S., Scholler, G., Langheinrich, M., and Roots, I.: Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort (Hypericum perforatum). J Clin Psychopharmacol 22 (2002), 46-54.